Marksans Pharma Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Total Qtr Revenue cr | 774.57 | 741.98 | 625.63 | 724.98 | 709.70 |
| Other Income Qtr Cr | 20.14 | 21.57 | 5.64 | 16.52 | 27.85 |
| Operating Revenues Qtr | 754.43 | 720.41 | 619.99 | 708.46 | 681.85 |
Loading chart... | |||||
Operating Expenses Qtr | 593.68 | 575.92 | 519.87 | 582.70 | 543.08 |
Operating Profit Qtr | 160.74 | 144.49 | 100.12 | 125.75 | 138.76 |
EBITDA Qtr Cr | 180.89 | 166.06 | 105.76 | 142.27 | 166.61 |
Depreciation Qtr | 24.33 | 26.92 | 23.10 | 22.74 | 20.69 |
Net Profit Qtr | 113.20 | 98.25 | 58.32 | 90.55 | 104.56 |
Basic EPS Qtr | 2.50 | 2.17 | 1.29 | 2.00 | 2.31 |
Open Demat Account